Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis

International Journal of Cardiology

Volumn 221, Issue , 2016, Pages 97-106

  Pagnesi, Matteo ^a   Martino, Enrico A ^a   Chiarito, Mauro ^a   Mangieri, Antonio ^a   Jabbour, Richard J ^a,b,c   Van Mieghem, Nicolas M ^d   Kodali, Susheel K ^e   Godino, Cosmo ^a   Landoni, Giovanni ^a,f   Colombo, Antonio ^a,b,f   Latib, Azeem ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^f VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Brain injury; Cerebral ischemia; Cerebral protection device; Magnetic resonance imaging; Meta analysis; TAVI

Indexed keywords

AORTA STENOSIS; ARTICLE; BRAIN INJURY; BRAIN PROTECTION; BRAIN REGION; CEREBROVASCULAR ACCIDENT; DEVICE EMBOLIZATION; DIFFUSION WEIGHTED IMAGING; HUMAN; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF EXPANDING STENT; SILENT BRAIN INJURY; SYSTEMATIC REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSIENT ISCHEMIC ATTACK; ADVERSE EFFECTS; AORTIC VALVE STENOSIS; ASYMPTOMATIC DISEASE; EMBOLIC PROTECTION DEVICE; POSTOPERATIVE COMPLICATIONS; PROCEDURES; STATISTICS AND NUMERICAL DATA; STROKE; TREATMENT OUTCOME;

AORTIC VALVE STENOSIS; ASYMPTOMATIC DISEASES; DIFFUSION MAGNETIC RESONANCE IMAGING; EMBOLIC PROTECTION DEVICES; HUMANS; POSTOPERATIVE COMPLICATIONS; STROKE; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84977602928     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.06.143     Document Type: Article

References (57)

1. [1] Cribier, A., Eltchaninoff, H., Bash, A., Borenstein, N., Tron, C., Bauer, F., et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106 (2002), 3006–3008.
2. [2] Leon, M.B., Smith, C.R., Mack, M., Miller, D.C., Moses, J.W., Svensson, L.G., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 363 (2010), 1597–1607.
3. [3] Smith, C.R., Leon, M.B., Mack, M.J., Miller, D.C., Moses, J.W., Svensson, L.G., et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N. Engl. J. Med. 364 (2011), 2187–2198.
4. [4] Vahanian, A., Alfieri, O., Andreotti, F., Antunes, M.J., Barón-Esquivias, G., Baumgartner, H., et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. J. Cardiothorac. Surg. 42 (2012), S1–S44.
5. [5] Nishimura, R.A., Otto, C.M., Bonow, R.O., Carabello, B.A., Erwin, J.P., Guyton, R.A., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 63 (2014), e57–e185.
6. [6] Leon, M.B., Smith, C.R., Mack, M.J., Makkar, R.R., Svensson, L.G., Kodali, S.K., et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N. Engl. J. Med. 374 (2016), 1609–1620.
7. [7] Thyregod, H.G.H., Steinbrüchel, D.A., Ihlemann, N., Nissen, H., Kjeldsen, B.J., Petursson, P., et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J. Am. Coll. Cardiol. 65 (2015), 2184–2194.
8. [8] Miller, D.C., Blackstone, E.H., Mack, M.J., Svensson, L.G., Kodali, S.K., Kapadia, S., et al. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J. Thorac. Cardiovasc. Surg. 143 (2012), 832–843.
9. [9] Eggebrecht, H., Schmermund, A., Voigtländer, T., Kahlert, P., Erbel, R., Mehta, R.H., Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 8 (2012), 129–138.
10. [10] Van Mieghem, N.M., Schipper, M.E.I., Ladich, E., Faqiri, E., van der Boon, R., Randjgari, A., et al. Histopathology of embolic debris captured during transcatheter aortic valve replacement. Circulation 127 (2013), 2194–2201.
11. [11] Nombela-Franco, L., Webb, J.G., de Jaegere, P.P., Toggweiler, S., Nuis, R.J., Dager, A.E., et al. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation 126 (2012), 3041–3053.
12. [12] Bosmans, J., Bleiziffer, S., Gerckens, U., Wenaweser, P., Brecker, S., Tamburino, C., et al. The incidence and predictors of early- and mid-term clinically relevant neurological events after transcatheter aortic valve replacement in real-world patients. J. Am. Coll. Cardiol. 66 (2015), 209–217.
13. [13] Kodali, S.K., Williams, M.R., Smith, C.R., Svensson, L.G., Webb, J.G., Makkar, R.R., et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N. Engl. J. Med. 366 (2012), 1686–1695.
14. [14] Athappan, G., Gajulapalli, R.D., Tuzcu, M.E., Svensson, L.G., Kapadia, S.R., A systematic review on the safety of second-generation transcatheter aortic valves. EuroIntervention 11 (2016), 1034–1043.
15. [15] Spaziano, M., Francese, D.P., Leon, M.B., Généreux, P., Imaging and functional testing to assess clinical and subclinical neurological events after transcatheter or surgical aortic valve replacement: a comprehensive review. J. Am. Coll. Cardiol. 64 (2014), 1950–1963.
16. [16] Bernick, C., Kuller, L., Dulberg, C., Longstreth, W.T., Manolio, T., Beauchamp, N., et al. Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology 57 (2001), 1222–1229.
17. [17] Vermeer, S.E., Hollander, M., van Dijk, E.J., Hofman, A., Koudstaal, P.J., Breteler, M.M.B., et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 34 (2003), 1126–1129.
18. [18] Vermeer, S.E., Longstreth, W.T., Koudstaal, P.J., Silent brain infarcts: a systematic review. Lancet Neurol. 6 (2007), 611–619.
19. [19] Barber, P.A., Hach, S., Tippett, L.J., Ross, L., Merry, A.F., Milsom, P., Cerebral ischemic lesions on diffusion-weighted imaging are associated with neurocognitive decline after cardiac surgery. Stroke 39 (2008), 1427–1433.
20. [20] Vermeer, S.E., Prins, N.D., den Heijer, T., Hofman, A., Koudstaal, P.J., Breteler, M.M.B., Silent brain infarcts and the risk of dementia and cognitive decline. N. Engl. J. Med. 348 (2003), 1215–1222.
21. [21] Fanning, J.P., Walters, D.L., Platts, D.G., Eeles, E., Bellapart, J., Fraser, J.F., Characterization of neurological injury in transcatheter aortic valve implantation: how clear is the picture?. Circulation 129 (2014), 504–515.
22. [22] Rossow, C.F., McCabe, J.M., Protection from cerebral embolic events during transcatheter aortic valve replacement. Curr. Cardiol. Rep., 18, 2016, 16.
23. [23] DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Control. Clin. Trials 7 (1986), 177–188.
24. [24] Wan, X., Wang, W., Liu, J., Tong, T., Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med. Res. Methodol., 14, 2014, 135.
25. [25] Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gøtzsche, P.C., Ioannidis, J.P.A., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ, 339, 2009, b2700.
26. [26] Higgins, J.P.T., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327 (2003), 557–560.
27. [27] Sterne, J.A., Egger, M., Smith, G.D., Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ 323 (2001), 101–105.
28. [28] Kahlert, P., Knipp, S.C., Schlamann, M., Thielmann, M., Al-Rashid, F., Weber, M., et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 121 (2010), 870–878.
29. [29] Ghanem, A., Müller, A., Nähle, C.P., Kocurek, J., Werner, N., Hammerstingl, C., et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J. Am. Coll. Cardiol. 55 (2010), 1427–1432.
30. [30] Arnold, M., Schulz-Heise, S., Achenbach, S., Ott, S., Dörfler, A., Ropers, D., et al. Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging. JACC. Cardiovasc. Interv. 3 (2010), 1126–1132.
31. [31] Rodés-Cabau, J., Dumont, E., Boone, R.H., Larose, E., Bagur, R., Gurvitch, R., et al. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J. Am. Coll. Cardiol. 57 (2011), 18–28.
32. [32] Astarci, P., Glineur, D., Kefer, J., D'Hoore, W., Renkin, J., Vanoverschelde, J.L., et al. Magnetic resonance imaging evaluation of cerebral embolization during percutaneous aortic valve implantation: comparison of transfemoral and trans-apical approaches using Edwards Sapiens valve. Eur. J. Cardiothorac. Surg. 40 (2011), 475–479.
33. [33] Fairbairn, T.A., Mather, A.N., Bijsterveld, P., Worthy, G., Currie, S., Goddard, A.J.P., et al. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart 98 (2012), 18–23.
34. [34] Ghanem, A., Kocurek, J., Sinning, J.M., Wagner, M., Becker, B.V., Vogel, M., et al. Cognitive trajectory after transcatheter aortic valve implantation. Circ. Cardiovasc. Interv. 6 (2013), 615–624.
35. [35] Knipp, S.C., Kahlert, P., Jokisch, D., Schlamann, M., Wendt, D., Weimar, C., et al. Cognitive function after transapical aortic valve implantation: a single-centre study with 3-month follow-up. Interact. Cardiovasc. Thorac. Surg. 16 (2013), 116–122.
36. [36] Astarci, P., Price, J., Glineur, D., D'Hoore, W., Kefer, J., Elkhoury, G., et al. Cerebral embolization during percutaneous valve implantation does not occur during balloon inflation valvuloplasty: prospective diffusion-weighted brain MRI study. J. Heart Valve Dis. 22 (2013), 79–84.
37. [37] Ghanem, A., Müller, A., Sinning, J.M., Kocurek, J., Becker, B.V., Vogel, M., et al. Prognostic value of cerebral injury following transfemoral aortic valve implantation. EuroIntervention 8 (2013), 1296–1306.
38. [38] Alassar, A., Soppa, G., Edsell, M., Rich, P., Roy, D., Chis Ster, I., et al. Incidence and mechanisms of cerebral ischemia after transcatheter aortic valve implantation compared with surgical aortic valve replacement. Ann. Thorac. Surg. 99 (2015), 802–808.
39. [39] Uddin, A., Fairbairn, T.A., Djoukhader, I.K., Igra, M., Kidambi, A., Motwani, M., et al. Consequence of cerebral embolism after transcatheter aortic valve implantation compared with contemporary surgical aortic valve replacement: effect on health-related quality of life. Circ. Cardiovasc. Interv., 8, 2015, e001913.
40. [40] Samim, M., Hendrikse, J., van der Worp, H.B., Agostoni, P., Nijhoff, F., Doevendans, P.A., et al. Silent ischemic brain lesions after transcatheter aortic valve replacement: lesion distribution and predictors. Clin. Res. Cardiol. 104 (2015), 430–438.
41. [41] Bijuklic, K., Haselbach, T., Witt, J., Krause, K., Hansen, L., Gehrckens, R., et al. Increased risk of cerebral embolization after implantation of a balloon-expandable aortic valve without prior balloon valvuloplasty. JACC. Cardiovasc. Interv. 8 (2015), 1608–1613.
42. [42] Abdul-Jawad Altisent, O., Ferreira-Gonzalez, I., Marsal, J.R., Ribera, A., Auger, C., Ortega, G., et al. Neurological damage after transcatheter aortic valve implantation compared with surgical aortic valve replacement in intermediate risk patients. Clin. Res. Cardiol., 2015.
43. [43] Wendt, D., Kleinbongard, P., Knipp, S., Al-Rashid, F., Gedik, N., El Chilali, K., et al. Intraaortic protection from embolization in patients undergoing transaortic transcatheter aortic valve implantation. Ann. Thorac. Surg. 100 (2015), 686–691.
44. [44] Lansky, A.J., Schofer, J., Tchetche, D., Stella, P., Pietras, C.G., Parise, H., et al. A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur. Heart J. 36 (2015), 2070–2078.
45. [45] Rodés-Cabau, J., Kahlert, P., Neumann, F.J., Schymik, G., Webb, J.G., Amarenco, P., et al. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study. JACC. Cardiovasc. Interv. 7 (2014), 1146–1155.
46. [46] Samim, M., Agostoni, P., Hendrikse, J., Budde, R.P.J., Nijhoff, F., Kluin, J., et al. Embrella embolic deflection device for cerebral protection during transcatheter aortic valve replacement. J. Thorac. Cardiovasc. Surg. 149 (2015), 799–805.
47. [47] Fanning, J.P., Wesley, A.J., Walters, D.L., Platts, D.G., Fraser, J.F., The posterior circulation and right hemisphere are particularly vulnerable to neurological insult during transcatheter aortic valve replacement (TAVR). American Heart Association Scientific Sessions 2015, November 9, 2015 (Orlando, FL, USA).
48. [48] Leclercq, F., Labour, J., de Champfleur, N.M., Macia, J.C., Lattuca, B., Schmutz, L., et al. Periprocedural cerebral ischemic events with TAVI performed without prior balloon dilatation of the aortic valve: a randomized prospective study. American Heart Association Scientific Sessions 2015, November 9, 2015 (Orlando, FL, USA).
49. [49] Bijuklic, K., Haselbach, T., Witt, J., Krause, K., Hansen, L., Gehrkens, R., et al. Impact of aortic valve type on cerebral ischemic lesions in DW-MRI after TAVR. Transcatheter Cardiovascular Therapeutics 2015, October 10 to 15, 2015 (San Francisco, CA, USA).
50. [50] Lansky, A., Brown, D., Pena, C., Pietras, C., Parise, H., Brickman, A., et al. Neurologic complications of contemporary unprotected trans-aortic valve replacement: final results of a prospective multicenter study to evaluate the neuro-embolic consequences of TAVR in the United States (the Neuro-TAVR Trial). PCR London Valves Congress, September 21, 2015 (Berlin, Germany).
51. [51] Linke, A., Haussig, S., Dwyer, M.G., Mangner, N., Lehmkuhl, L., Woitek, F., et al. A prospective, randomized trial of cerebral embolic protection in high-risk patients with aortic stenosis undergoing transcatheter aortic valve replacement. Transcatheter Cardiovascular Therapeutics Congress, September 13, 2014 (Washington, WA, USA).
52. [52] Van Mieghem, N.M., Van Gils, L., Ahmad, H., van Kesteren, F., van der Werf, H.W., van den Heuvel, A.F., et al. MISTRAL-C: MRI investigation in TAVI with claret. Transcatheter Cardiovascular Therapeutics Congress, October 14, 2015 (San Francisco, CA, USA).
53. [53] Kahlert, P., Al-Rashid, F., Döttger, P., Mori, K., Plicht, B., Wendt, D., et al. Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study. Circulation 126 (2012), 1245–1255.
54. [54] Erdoes, G., Basciani, R., Huber, C., Stortecky, S., Wenaweser, P., Windecker, S., et al. Transcranial Doppler-detected cerebral embolic load during transcatheter aortic valve implantation. Eur. J. Cardiothorac. Surg. 41 (2012), 778–783.
55. [55] Drews, T., Pasic, M., Buz, S., Unbehaun, A., Dreysse, S., Kukucka, M., et al. Transcranial Doppler sound detection of cerebral microembolism during transapical aortic valve implantation. Thorac. Cardiovasc. Surg. 59 (2011), 237–242.
56. [56] Albach, F.N., Brunecker, P., Usnich, T., Villringer, K., Ebinger, M., Fiebach, J.B., et al. Complete early reversal of diffusion-weighted imaging hyperintensities after ischemic stroke is mainly limited to small embolic lesions. Stroke 44 (2013), 1043–1048.
57. [57] Bonati, L.H., Jongen, L.M., Haller, S., Flach, H.Z., Dobson, J., Nederkoorn, P.J., et al. New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS). Lancet Neurol. 9 (2010), 353–362.